Skip to content
Screener

MBX Biosciences, Inc. MBX Shares (Diluted)

Shares (Diluted) at other companies

Eli Lilly logo
Eli LillyLLY
893.7M-0.7%
Amgen logo
AmgenAMGN
544M+0.6%
Viking Therapeutics logo
Viking TherapeuticsVKTX
115.6M+3.1%
Amylyx Pharmaceuticals, Inc. logo
Amylyx Pharmaceuticals, Inc.AMLX
111.2M+24.7%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
194.8M+2.4%
Nurix Therapeutics, Inc. logo
Nurix Therapeutics, Inc.NRIX
111.1M+32.4%

Other financials

Income statement

See full
Operating income-$27.3M-2.8%
Net income-$23.5M+1.5%
EPS (diluted)-$0.50+29.6%

Balance sheet

See full
Cash & equivalents$45.2M+51.2%
Total debt$555.0K+327%
Total equity$437.8M+85.9%
Total assets$452.7M+84.1%

Cash flow

See full
Operating cash flow-$20.2M+10.9%
CapEx$437.0K+1,357%
Free cash flow-$20.6M+9.1%

Valuation

See full
Market cap$3.19B+719%
Enterprise value$3.15B+798%

Returns & leverage

See full
Return on equity-25.7%
Debt / equity0.0×
Current ratio30.8×+7.5×

Where this comes from

Reported directly by MBX Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.

The source filing: MBX Biosciences, Inc.’s 10-Q, filed May 7, 2026. Open the filing →

Filed
May 7, 2026, 9:03 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-210593

FAQ

What is MBX Biosciences, Inc.'s shares (diluted)?
MBX Biosciences, Inc. (MBX) reported shares (diluted) of 46.6M in Q1 2026.
How has MBX Biosciences, Inc.'s shares (diluted) changed year-over-year?
MBX Biosciences, Inc.'s shares (diluted) increased by 39.4% year-over-year, from 33.4M to 46.6M.
What does shares (diluted) mean?
The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.

Ask your AI about MBX Biosciences, Inc.'s shares (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude